Companies / Bristol-Myers Squibb
Bristol-Myers Squibb
Company- Registered trials
- 2869
- Ongoing
- 435/ 15%
- Completed
- 1899
- Related drugs
- 19
- Related conditions
- 25
Clinical trial landscape
2869 registered studies reference this company or one of its brands. The split below shows how many are ongoing versus completed per phase.
| Phase | Total | Ongoing | Completed | Split |
|---|---|---|---|---|
| Phase 2 | 808 | 135 | 476 | |
| Phase 1 | 680 | 57 | 519 | |
| Unknown | 453 | 98 | 288 | |
| Phase 3 | 392 | 64 | 282 | |
| Phase 1/2 | 236 | 49 | 123 | |
| Phase 4 | 149 | 10 | 110 | |
| Not applicable | 92 | 8 | 70 | |
| Phase 2/3 | 39 | 11 | 20 | |
| Early Phase 1 | 20 | 3 | 11 | |
| All phases | 2869 | 435 | 1899 |
Ongoing Completed Balance withdrawn, terminated, or status unreported.
Study records: ClinicalTrials.gov →
Recent developments
Headlines link to the original publisher. Sources limited to a reviewed list of journals, regulators, and medical press.